论文信息 - Decitabine (DAC) Can Be Safely Reduced After Achievement of Best Response In Patients (pts) with Myelodysplastic Syndrome (MDS) - 字舞流文

Decitabine (DAC) Can Be Safely Reduced After Achievement of Best Response In Patients (pts) with Myelodysplastic Syndrome (MDS)

H. Kantarjian | J. Cortes | T. Kadia | F. Ravandi | G. Borthakur | E. Jabbour | S. O'brien | M. Brandt | G. G. Manero | A. Cornelison